• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用水溶性光敏剂ATX-S10通过光动力疗法选择性封闭脉络膜新生血管。

Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.

作者信息

Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T

机构信息

Department of Ophthalmology, Osaka City, University Medical School, Osaka, Japan.

出版信息

Lasers Surg Med. 1999;24(3):209-22. doi: 10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>3.0.co;2-l.

DOI:10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>3.0.co;2-l
PMID:10229152
Abstract

BACKGROUND AND OBJECTIVE

To determine the optimal treatment parameters for selective occlusion of choroidal neovascularization (CNV) by photodynamic therapy (PDT) by using the photosensitizer ATX-S10 and a diode laser (wavelength = 670 nm).

MATERIALS AND METHODS

Experimental CNV was induced in rat fundi by argon laser photocoagulation. The distribution of ATX-S10 in the chorioretina was analyzed by fluorescence microscopy, and the optimal treatment parameters for selective occlusion of CNV were investigated by changing the dosage and timing of laser irradiation. CNV closure and resulting damage of the surrounding tissue were documented by fluorescein angiography and light and electron microscopies.

RESULTS

Fluorescence of ATX-S10 was observed to be localized in the vascular lumen of the retina and choroid within 5 min after dye injection and increased in intensity in CNV up to 2-6 h and decreased rapidly in normal tissue. Laser irradiation with radiant exposures of 7.4 J/cm2 applied immediately after dye injection or with 22.0 J/cm2 at 2-4 h later effectively occluded the induced CNV without causing significant damage to normal retinal capillaries and large choroidal vessels.

CONCLUSIONS

PDT using ATX-S10 can selectively occlude CNV. ATX-S10 is a potentially useful photosensitizer for the treatment of CNV.

摘要

背景与目的

通过使用光敏剂ATX-S10和二极管激光器(波长 = 670 nm)来确定光动力疗法(PDT)选择性封闭脉络膜新生血管(CNV)的最佳治疗参数。

材料与方法

通过氩激光光凝在大鼠眼底诱导实验性CNV。用荧光显微镜分析ATX-S10在脉络膜视网膜中的分布,并通过改变激光照射的剂量和时间来研究选择性封闭CNV的最佳治疗参数。通过荧光素血管造影以及光镜和电镜记录CNV的封闭情况和周围组织由此产生的损伤。

结果

在注射染料后5分钟内观察到ATX-S10的荧光定位于视网膜和脉络膜的血管腔内,在CNV中荧光强度在2 - 6小时内增加,而在正常组织中迅速降低。在注射染料后立即给予7.4 J/cm²的辐射曝光进行激光照射,或在2 - 4小时后给予22.0 J/cm²,可有效封闭诱导产生的CNV,且不会对正常视网膜毛细血管和大脉络膜血管造成显著损伤。

结论

使用ATX-S10的PDT可选择性封闭CNV。ATX-S10是一种用于治疗CNV的潜在有用的光敏剂。

相似文献

1
Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.使用水溶性光敏剂ATX-S10通过光动力疗法选择性封闭脉络膜新生血管。
Lasers Surg Med. 1999;24(3):209-22. doi: 10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>3.0.co;2-l.
2
Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.新型光敏剂ATX-S10(钠)对猴脉络膜新生血管的选择性光动力效应。
Arch Ophthalmol. 2000 May;118(5):650-8. doi: 10.1001/archopht.118.5.650.
3
PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.用ATX-S10(Na)对猴脉络膜新生血管进行光动力疗法:早期激光照射用于选择性闭塞的不适当性
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45.
4
Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.使用亲水性光敏剂ATX-S10(Na)进行光动力疗法对大鼠实验性脉络膜新生血管形成的长期疗效
Lasers Surg Med. 2000;26(1):48-57. doi: 10.1002/(sici)1096-9101(2000)26:1<48::aid-lsm8>3.0.co;2-z.
5
Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.亲水性光敏剂单-L-天冬酰胺基二氢卟吩e6对实验性脉络膜新生血管的光动力治疗
Retina. 2001;21(5):499-508. doi: 10.1097/00006982-200110000-00013.
6
[Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].[ATX-S 10(钠)光动力疗法对实验性脉络膜新生血管形成的影响]
Nippon Ganka Gakkai Zasshi. 2006 Jun;110(6):445-53.
7
Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.四磺酸酞菁锌(ZnPcS4):一种用于脉络膜新生血管光动力治疗的新型光敏剂。
J Ocul Pharmacol Ther. 2007 Aug;23(4):377-86. doi: 10.1089/jop.2006.0135.
8
Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.脂质体苯并卟啉衍生物维替泊芬光动力疗法。对猴子脉络膜新生血管的选择性治疗。
Ophthalmology. 1996 Mar;103(3):427-38. doi: 10.1016/s0161-6420(96)30675-1.
9
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.通过将靶向维替泊芬递送至由归巢肽介导至血管内皮生长因子受体-2的实验性脉络膜新生血管来进行选择性光动力疗法。
Arch Ophthalmol. 2004 Jul;122(7):1002-11. doi: 10.1001/archopht.122.7.1002.
10
Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization.大鼠实验性脉络膜新生血管中光敏剂选择性积聚及其光动力效应的动态观察
Retina. 2001;21(2):126-31. doi: 10.1097/00006982-200104000-00005.

引用本文的文献

1
Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.光动力疗法可通过中性粒细胞聚集诱导针对小鼠细菌性关节炎的保护性固有免疫应答。
PLoS One. 2012;7(6):e39823. doi: 10.1371/journal.pone.0039823. Epub 2012 Jun 26.
2
Photodynamic therapy with ATX-S10.Na(II) inhibits synovial sarcoma cell growth.使用ATX-S10.Na(II)进行光动力疗法可抑制滑膜肉瘤细胞生长。
Clin Orthop Relat Res. 2008 Jul;466(7):1726-33. doi: 10.1007/s11999-008-0284-6. Epub 2008 May 9.
3
Current and future treatment options for nonexudative and exudative age-related macular degeneration.
非渗出性和渗出性年龄相关性黄斑变性的当前及未来治疗选择
Drugs Aging. 2004;21(15):967-92. doi: 10.2165/00002512-200421150-00002.
4
Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.使用亲水性二氢卟吩光敏剂ATX-S10(Na)和二极管激光对实验性肿瘤进行光动力治疗。
Jpn J Cancer Res. 2000 Jul;91(7):753-9. doi: 10.1111/j.1349-7006.2000.tb01009.x.